← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2013Last known activity
Jul 15, 2017
Timeline
2010s
- Jun 1, 2013
Meander Medical Center— Founded
Drugs by trial phase (11 distinct, 9 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Angina, Unstable
- Carcinoma in Situ
- Cardio-Renal Syndrome
- Cervical Intraepithelial Neoplasia
- Cholecystolithiasis
- Cholelithiasis
- Colonic Neoplasms
- Dyssomnias
- Gallstones
- Heart Failure
- Infarction
- Invasive Fungal Infections
- Multiple Myeloma
- Mycoses
- Myocardial Infarction
- Neoplasms
- Neoplasms, Plasma Cell
- Non-ST Elevated Myocardial Infarction
- Parasomnias
- Postoperative Pain
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Sleep Wake Disorders
- Syndrome
Recent trials (12)
- NCT03184194CollaboratorPhase 2Jul 15, 2017
- NCT02685046CollaboratorPhase 2Apr 1, 2016
- NCT02669459CollaboratorPhase 3Mar 1, 2016
- NCT02317198CollaboratorPhase 4Jun 1, 2013
- NCT01199406Lead sponsorPhase 4Jul 1, 2009
- NCT01199406Study directorPhase 4Jul 1, 2009
- NCT01199406Overall official - principal investigatorPhase 4Jul 1, 2009
- NCT01199406Study chairPhase 4Jul 1, 2009
- NCT00893555CollaboratorPhase 3Apr 1, 2009
- NCT00388661Lead sponsorPhase 3Apr 1, 2007
- NCT00356733Overall official - principal investigatorPhase 3Jan 1, 2007
- NCT00404456Lead sponsorPhase 3Apr 1, 2005
Details
- Founded
- Amersfoot, NL Jun 1, 2013
- Last known activity
- Jul 15, 2017